According to MarketsandMarkets™, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 ...
Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered ...
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered ...
At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...
Assertio Holdings, Inc. ("Assertio" or the "Company") today announced that results of a clinical trial investigating a novel ...
As stricter fuel regulations and pressures intensify for a solution to the rising greenhouse gas emissions, the maritime ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Artificial intelligence is redefining how fire tests are used in polyurethane foam R&D, delivering faster insights and ...
In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback